Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 1 47-1, 2000, Pages

  Nagatomo, Yoshitatsu ^a   Carabello, Blase A ^a   Coker, Mytsi L ^a   McDermott, Paul J ^a   Nemoto, Shintaro ^a   Hamawaki, Masayoshi ^a   Spinale, Francis G ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Hypertrophy; Left ventricular overload; Matrix metalloproteinase; Myocardial remodeling; Tissue inhibitor of metalloproteinases

Indexed keywords

COLLAGENASE; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOG; HEART HEMODYNAMICS; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; IMMUNOBLOTTING; INHIBITION KINETICS; MITRAL VALVE REGURGITATION; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; ZYMOGRAPHY;

EID: 0033956473     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.1.h151     Document Type: Article

References (49)

1. Aggeler, J., S. M. Frisch, and Z. Werb. Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts. J. Cell Biol. 98: 1662-1671, 1984.
2. Aoyagi, T., A. M. Fujii, M. F. Flanagan, L. W. Arnold, K. W. Brathwaite, S. D. Colan, and I. Mirsky. Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep: systolic dysfunction precedes diastolic dysfunction. Circulation 88: 2415-2425, 1993.
3. Borg, T. K., and L. Terracio. Interaction of the extracellular matrix with cardiac myocytes during development and disease. In: Cardiac Myocyte-Connective Tissue Interactions in Health and Disease, edited by T. R. Robinson and R. K. H. Kinne. Basel: Karger, 1990, p. 113-130.
4. Brenner, D. A., M. O'Hara, P. Angel, M. Chojkler, and M. Karin. Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha. Nature 337: 661-663, 1989.
5. Cawston, T. E., V. A. Curry, I. M. Clark, and B. L. Hazleman. Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase. Biochem. J. 269: 183-187, 1990.
6. Dell'Italia, L. J., E. Balcells, Q. C. Meng, X. Su, D. Schultz, S. P. Bishop, N. Machida, I. M. Straeter-Knowlen, G. H. Hankes, R. Dillon, R. E. Cartee, and S. Oparil. Volume overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am. J. Physiol. Heart Circ. Physiol. 273: H961-H970, 1997.
7. Dell'Italia, L. J., Q. C. Meng, E. Balcells, I. M. Straeter-Knowlen, G. Hankes, R. Dillon, R. E. Carter, R. Orr, S. P. Bishop, S. Oparil, and T. S. Elton. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am. J. Physiol. Heart Circ. Physiol. 269: H2065-H2073, 1995.
8. Dollery, C. M., J. R. McEwan, and A. M. Henney. Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77: 863-868, 1995.
9. Edwards, D. R., P. P. Beaudry, T. D. Laing, V. Kowal, K. J. Leco, P. A. Leco, and M. S. Lim. The roles of tissue inhibitors of metalloproteinases in tissue remodeling and cell growth. Int. J. Obes. 20, Suppl.: S9-S15, 1996.
10. Factor, S. M. Role of extracellular matrix in dilated cardiomyopathy. Heart Failure 8: 260-268, 1994.
11. 2+ modulation. Circ. Res. 78: 302-311, 1996.
12. Frisch, S. M., and J. H. Morisaki. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell. Biol. 10: 6524-6532, 1990.
13. Gavras, H. Angiotensin converting enzyme inhibition and the heart. Hypertension 23: 813-818, 1994.
14. Gerdes, A. M., S. E. Campbell, and D. R. Hilbelink. Structural remodeling of cardiac myocytes in rats with arteriovenous fistulas. Lab. Invest. 59: 857-861, 1988.
15. Goldberg, G. I., B. L. Marmer, G. A. Grant, A. Z. Eisen, S. Wilhelm, and C. He. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloprotease designated TIMP. Proc. Natl. Acad. Sci. USA 86: 8207-8211, 1989.
16. Green, J., M. Wang, Y. E. Liu, L. A. Raymond, C. Rosen, and Y. E. Shi. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271: 30375-30380, 1996.
17. Grossman, W., D. Jones, and L. P. McLaurin. Wall stress patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 56: 56-64, 1975.
18. Gunja-Smith, Z., A. R. Morales, R. Romanelli, and J. F. Woessner. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy: role of metalloproteinases and pyridinoline cross links. Am. J. Pathol. 148: 1639-1648, 1996.
19. Hansen-Birkedal, H., W. G. I. Moore, M. K. Bodden, L. J. Windsor, B. Hansen-Birkedal, A. DeCarlo, and J. A. Engler. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4: 197-250, 1993.
20. Hatt, P. Y., K. Rakusan, P. Gastineau, and M. Laplace. Morphometry, and ultrastructure of heart hypertrophy induced by chronic volume overload (aorto-caval fistula in the rat). J. Mol. Cell. Cardiol. 11: 989-998, 1979.
21. He, C., S. M. Wilhelm, A. P. Pentland, B. L. Marmer, G. A. Grant, A. Z. Eisen, and G. I. Goldberg. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA 86: 2632-2636, 1989.
22. Imamura, T., P. J. McDermott, R. L. Kent, M. Nagatsu, G. Cooper IV, and B. A. Carabello. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload. Circ. Res. 75: 418-425, 1994.
23. Janicki, J. S., J. R. Henegar, S. E. Campbell, and S. C. Tyagi. Myocardial collagenase activity in experimental dilated cardiomyopathy. In: Wound Healing in Cardiovascular Disease, edited by K. T. Weber. New York: Futura, 1995, p. 73-81.
24. Koide, M., M. Nagatsu, M. R. Zile, M. Hamawaki, M. M. Swindle, G. Keech, G. DeFreyte, H. Tagawa, G. Cooper, and B. A. Carabello. Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. Circulation 95: 1601-1610, 1997.
25. Leco, K. J., R. Khokha, N. Pavloff, S. P. Hawkes, and D. R. Edwards. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269: 9352-9360, 1994.
26. Li, Y. Y., A. M. Feldman, Y. Sun, and C. F. McTiernan. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98: 1728-1734, 1998.
27. Linzbach, A. J. Heart failure from the point of view of quantitative anatomy. Am. J. Cardiol. 5: 370-382, 1960.
28. MacNaul, K. L., N. Chartrain, M. Lark, M. J. Tocci, and N. I. Hutchinson. Discordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts: synergistic effects of interleukin-1 and tumor necrosis factor-α on stromelysin expression. J. Biol. Chem. 265: 17238-17245, 1990.
29. Matsuo, T., B. A. Carabello, Y. Nagatomo, M. Koide, M. Hamawaki, M. R. Zile, and P. J. McDermott. Mechanisms of cardiac hypertrophy in canine volume overload. Am. J. Physiol. Heart Circ. Physiol. 275: H65-H74, 1998.
30. Murphy, G., M. I. Cockett, P. E. Stephens, B. J. Smith, and A. J. Docherty. Stromelysin is an activator of procollagenase. Biochem. J. 248: 265-268, 1987.
31. Nagase, H. Activational mechanisms of matrix metalloproteinases. Biol. Chem. 378: 151-160, 1997.
32. Obata, K., K. Iwata, Y. Okada, Y. Kohrin, E. Ohuchi, S. Yoshida, M. Shinmei, and T. Hayakawa. A one step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin. Chim. Acta 211: 59-72, 1992.
33. Olivetti, G., R. Ricci, C. Lagrasta, E. Maniga, E. H. Sonnenblick, and P. Anversa. Cellullar basis of wall remodeling in long-term pressure overload-induced right ventricular hypertrophy in rats. Circ. Res. 63: 648-657, 1988.
34. Overall, C. M., J. L. Wrana, and J. Sodek. Transcriptional and post-transcriptional regulation of 72 kDa gelatinase/type IV collagenase by transforming growth factor β-1 in human fibroblasts. J. Biol. Chem. 266: 14064-14071, 1991.
35. Rees, R. C., and D. W. Cottam. Regulation of the matrix metalloproteinases: their role in tumor invasion and metastasis (review). Int. J. Oncol. 2: 861-872, 1993.
36. Ries, C., and P. E. Petrides. Cytokine regulation of matrix metalloproteinase activity and regulatory dysfunction in disease. Biol. Chem. 376: 345-355, 1995.
37. Robinson, T. F., L. Cohen-Gould, and S. M. Factor. Skeletal framework of mammalian heart muscle. Arrangement of inter-and pericellular connective tissue structures. Lab. Invest. 49: 482-498, 1983.
38. Saito, H., and M. Seiki. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405, 1993.
39. Shonthal, A., P. Herrlich, H. J. Rahmsdorf, and H. Ponta. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54: 325-334, 1988.
40. Spinale, F. G., M. L. Coker, C. V. Thomas, J. D. Walker, R. Mukherjee, and L. Hebbar. Time dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ. Res. 82: 482-495, 1998.
41. Spinale, F. G., K. Ishihra, M. Zile, G. DeFryte, F. A. Crawford, and B. A. Carabello. The structural basis for changes in left ventricular function, and geometry due to chronic mitral regurgitation and following correction of the volume overload. J. Thorac. Cardiovasc. Surg. 106: 1147-1157, 1993.
42. 73 active site zine complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. USA 87: 364-368, 1990.
43. Stetler-Stevenson, W. G. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol. 148: 1345-1350, 1996.
44. Thomas, C. V., M. L. Coker, J. L. Zellner, J. R. Handy, A. J. Crumbley, and F. G. Spinale. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97: 1708-1718, 1998.
45. Weber, K. T., P. Anversa, P. W. Armstrong, C. G. Brilla, J. C. Burnett, J. M. Cruickshank, R. B. Devereux, T. D. Giles, N. Korsgaard, C. V. Leier, F. A. O. Mendelsohn, W. H. Motz, M. J. Mulvany, and B. E. Strauer. Remodeling and reparation of the cardiovascular system. J. Am. Coll. Cardiol. 20: 3-16, 1992.
46. Weber, K. T., and C. G. Brilla. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin system. Circulation 83: 1849-1865, 1991.
47. Werb, Z., and C. M. Alexander. Proteinases and matrix degradation. In: Textbook of Rheumatology, edited by W. N. Kelly, E. D. Harris, S. Ruddy, and C. B. Sledge. Philadelphia, PA: Saunders, 1993, p. 248-268.
48. Werb, Z., R. M. Hembry, G. Murphy, and J. Aggeler. Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J. Cell Biol. 102: 697-702, 1986.
49. Zhang, J., N. Fujimoto, K. Iwata, T. Sakai, Y. Okada, and T. Hayakawa. A one step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin. Chim. Acta 219: 1-14, 1993.